These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Clinical characteristics of pituitary adenomas with radiological calcification. Ogiwara T, Nagm A, Yamamoto Y, Hasegawa T, Nishikawa A, Hongo K. Acta Neurochir (Wien); 2017 Nov; 159(11):2187-2192. PubMed ID: 28825138 [Abstract] [Full Text] [Related]
43. Diagnostic approaches to pituitary adenomas. Drayer B, Kattah J, Rosenbaum A, Kennerdell J, Maroon J. Neurology; 1979 Feb; 29(2):161-9. PubMed ID: 571059 [Abstract] [Full Text] [Related]
44. Predictors of the outcome of transsphenoidal surgery for prolactin-secreting pituitary adenomas. Schlechte J, Vangilder J, Sherman B. J Clin Endocrinol Metab; 1981 Apr; 52(4):785-9. PubMed ID: 7193686 [Abstract] [Full Text] [Related]
45. [Endocrinological evaluation of sellar and suprasellar tumor cases (the ninth report)--on the PRL levels in the CSF (author's transl)]. Matsumura S, Mori S, Yoshimoto H, Ohta M, Uozumi T. No Shinkei Geka; 1977 Sep; 5(10):1057-63. PubMed ID: 909617 [Abstract] [Full Text] [Related]
50. Tortuosity of the cavernous carotid arteries causing sellar expansion simulating pituitary adenoma. Anderson RD. AJR Am J Roentgenol; 1976 Jun; 126(6):1203-10. PubMed ID: 179382 [Abstract] [Full Text] [Related]
51. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T. Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132 [Abstract] [Full Text] [Related]
52. The value of computed tomography in delineating suprasellar extension of pituitary adenomas. Pripstein S, Danoff B, Schnapf D, Lee KF, Kramer S. Neuroradiology; 1978 Oct; 16():462-3. PubMed ID: 745737 [Abstract] [Full Text] [Related]
54. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors. Schlechte JA, Sherman BM, Chapler FK, VanGilder J. J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539 [Abstract] [Full Text] [Related]
55. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect. Coculescu M, Simionescu N, Oprescu M, Alessandrescu D. Endocrinologie; 1983 Jun; 21(3):157-68. PubMed ID: 6635518 [Abstract] [Full Text] [Related]
56. Prolactin-secreting pituitary adenomas: neurosurgical management of 37 patients. Woosley RE, King JS, Talbert L. Fertil Steril; 1982 Jan; 37(1):54-60. PubMed ID: 7199482 [Abstract] [Full Text] [Related]
57. [Detection of pituitary adenomas by computerized tomography (author's transl)]. Lemaitre G, Linquette M, Fossati P, Cappoen JP. Ann Med Interne (Paris); 1982 Jan; 133(1):33-4. PubMed ID: 7065586 [Abstract] [Full Text] [Related]
58. Dynamic CT scanning for the evaluation of pituitary tumor invasion to the cavernous sinus. Inoue Y, Hakuba A, Takemoto K, Nemoto Y, Oda J, Onoyama Y, Nishio A, Nishimura S. Radiat Med; 1985 Jan; 3(4):192-6. PubMed ID: 3836437 [Abstract] [Full Text] [Related]
59. [Prolactinomas and "idiopathic" hyperprolactinemia. Case series]. Volpe A, Grasso A, Oliva A, Bramanti P, Leggiadro N, Musolino R, Meduri M. Riv Neurol; 1980 Jan; 50(5):350-61. PubMed ID: 6781058 [Abstract] [Full Text] [Related]
60. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery. Barbarino A, De Marinis L, Maira G, Menini E, Anile C. J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]